Plenary and Invited Talks
Cost-effectiveness of monoclonal antibodies and maternal vaccination programmes against RSV
An plentary talk given at the 17th Vaccine Congress
Infectious disease modelling and cost-effectiveness of RSV intervention strategies
An invited talk given at the World Vaccine Congress Europe
Selected talks
serojump Inferring infection timing and antibody kinetics from longitudinal serology
A talk given at European Scientific Working group on Influenza 2025.
Correlates of Protection through multidimensional immune modelling across respiratory viruses
A talk given at ISIRV 4th Correlates of Protection for Next generation of Influenza vaccines.
Memory B cell proliferation drives differences in neutralising responses between Adenovirus-vectored and mRNA vaccines
A talk given at the 12th Options for the control of influenza
Understanding drivers of differential immune responses to mRNA and adenovirus vectored COVID-19 vaccines A data-driven dynamic modelling analysis
A talk given at the Individual and population immunity to respiratory viruses
Post-vaccine HAI antibody kinetics are driven by pre-existing immune status
A talk given at the ESWI 2023